UY28959A1 - Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación. - Google Patents

Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.

Info

Publication number
UY28959A1
UY28959A1 UY28959A UY28959A UY28959A1 UY 28959 A1 UY28959 A1 UY 28959A1 UY 28959 A UY28959 A UY 28959A UY 28959 A UY28959 A UY 28959A UY 28959 A1 UY28959 A1 UY 28959A1
Authority
UY
Uruguay
Prior art keywords
oxabispidins
bispidins
diazabiciclo
nons
solvates
Prior art date
Application number
UY28959A
Other languages
English (en)
Spanish (es)
Inventor
Olsson Christina
Annika Bjore
Peter Bonn
Ulrik Gran
Johan Kajanus
Fritiof Ponten
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32710059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28959(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28959A1 publication Critical patent/UY28959A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY28959A 2004-06-15 2005-06-14 Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación. UY28959A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401539A SE0401539D0 (sv) 2004-06-15 2004-06-15 New compounds

Publications (1)

Publication Number Publication Date
UY28959A1 true UY28959A1 (es) 2006-01-31

Family

ID=32710059

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28959A UY28959A1 (es) 2004-06-15 2005-06-14 Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.

Country Status (22)

Country Link
US (2) US7648985B2 (https=)
EP (1) EP1765832B8 (https=)
JP (1) JP2008502678A (https=)
KR (1) KR20070039045A (https=)
CN (2) CN101525339A (https=)
AR (1) AR049823A1 (https=)
AU (2) AU2005254924B2 (https=)
BR (1) BRPI0512012A (https=)
CA (1) CA2568895A1 (https=)
DK (1) DK1765832T3 (https=)
ES (1) ES2434043T3 (https=)
IL (1) IL179560A0 (https=)
MX (1) MXPA06014692A (https=)
NO (1) NO20070148L (https=)
RU (1) RU2379311C9 (https=)
SE (1) SE0401539D0 (https=)
SG (1) SG153822A1 (https=)
TW (1) TW200612907A (https=)
UA (1) UA85877C2 (https=)
UY (1) UY28959A1 (https=)
WO (1) WO2005123748A1 (https=)
ZA (2) ZA200610418B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
JP2008543750A (ja) 2005-06-13 2008-12-04 アストラゼネカ アクチボラグ 心不整脈の処置用の新規オキサビスピジン化合物
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
JP2011524398A (ja) 2008-06-16 2011-09-01 エフ．ホフマン−ラ ロシュ アーゲー オレキシニン受容体アンタゴニストとしてのヘテロ芳香族モノアミド
TW201004963A (en) * 2008-07-03 2010-02-01 Targacept Inc Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
WO2010059119A1 (en) * 2008-11-21 2010-05-27 Astrazeneca Ab A combination of tert -butyl (2-{7- [2- (4-cyano-2- f luorophenoxy) ethyl] -9-oxa-3, 7-diazabicyclo [3.3.1] non-3- yl } ethyl) carbamate and certain antiarrhythmic benzofurans
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN117384037B (zh) * 2023-12-13 2024-03-08 山东国邦药业有限公司 一种二氟乙酸乙酯的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3503939A (en) * 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
CH488048A (de) 1969-06-12 1970-03-31 Inventa Ag Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung
DE2428792A1 (de) 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
JPS5772977A (en) 1980-10-23 1982-05-07 Dainippon Ink & Chem Inc Fluorine-containing diepoxy compound and its preparation
DE3112055A1 (de) 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4533713A (en) * 1983-05-06 1985-08-06 Minnesota Mining And Manufacturing Company Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
FI100151B (fi) 1992-09-04 1997-09-30 Nokia Mobile Phones Ltd Tehonsäästö matkaviestimessä
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
JPH06284071A (ja) 1993-01-27 1994-10-07 Casio Comput Co Ltd 無線受信機
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
FR2713081B1 (fr) 1993-11-29 1996-01-12 Celsa Lg Filtre sanguin perfectionné à deux séries de pattes en pétales.
US5831099A (en) * 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
CZ20013608A3 (cs) 1999-04-09 2002-05-15 Astrazeneca Ab Adamantanové deriváty
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
AR030756A1 (es) 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
SE0101323D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0201662D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Pharmaceutical combination
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
CA2568895A1 (en) 2005-12-29
US7648985B2 (en) 2010-01-19
SE0401539D0 (sv) 2004-06-15
US20090005558A1 (en) 2009-01-01
AU2005254924B2 (en) 2009-08-27
EP1765832A1 (en) 2007-03-28
MXPA06014692A (es) 2007-02-12
CN101525339A (zh) 2009-09-09
US20090270383A1 (en) 2009-10-29
EP1765832B8 (en) 2013-09-25
SG153822A1 (en) 2009-07-29
TW200612907A (en) 2006-05-01
ES2434043T3 (es) 2013-12-13
NO20070148L (no) 2007-01-09
RU2006145202A (ru) 2008-07-20
BRPI0512012A (pt) 2008-02-06
WO2005123748A1 (en) 2005-12-29
AU2005254924A1 (en) 2005-12-29
DK1765832T3 (da) 2013-10-21
CN1968956A (zh) 2007-05-23
AU2009222548A1 (en) 2009-10-22
IL179560A0 (en) 2007-05-15
EP1765832B1 (en) 2013-08-14
JP2008502678A (ja) 2008-01-31
ZA200610418B (en) 2008-07-30
RU2379311C9 (ru) 2010-05-27
AR049823A1 (es) 2006-09-06
KR20070039045A (ko) 2007-04-11
RU2379311C2 (ru) 2010-01-20
ZA200710111B (en) 2009-08-26
UA85877C2 (uk) 2009-03-10

Similar Documents

Publication Publication Date Title
AR048039A1 (es) Profarmacos de piperazina y agentes antivirales de piperidina sustituidos
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
AR053569A1 (es) Derivados de pirazol
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
AR077765A1 (es) Inhibidores de los virus flaviviridae
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
UY31189A1 (es) Compuestos heterocíclicos
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
CR9881A (es) Polimorfos de la sal benzoato de 2-[[6-[(3r)-3amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo y metodos de uso para los mismos
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
UY30500A1 (es) Compuestos de azabencimidazolilo
CY1112921T1 (el) Ενεργοποιητες γλυκοκινασης πυρρολιδινονης
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
UY29893A1 (es) Derivados de pirazina
CR8756A (es) Derivados de acido carboxilico bencimidazolona
NO20070089L (no) DPP-IV inhibitorer
CO6341477A2 (es) Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos
SG163540A1 (en) Substituted glycinamides having an antithrombotic and factor xa- inhibiting effect
AR063027A1 (es) Derivados de sulfonamida
UY28959A1 (es) Compuestos basados en bispidinas, 3,7-diazabiciclo (3,3,1)nonanos, particularmente oxabispidinas, sus sales y solvatos, composiciones conteniéndolos y procedimientos de preparación.
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
AR056860A1 (es) Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores